Naturecell Co., Ltd. logo

Naturecell Co., Ltd. (007390)

Market Closed
10 Aug, 06:30
KRX SM KRX SM
22,900. 00
+650
+2.9213%
1.12T Market Cap
- P/E Ratio
- Div Yield
402,821 Volume
- Eps
22,250
Previous Close
Add Transaction
Day Range
22,300 23,700
Year Range
16,550 36,950
Want to track 007390 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

007390 closed today higher at ₩22,900, an increase of 2.9213% from yesterday's close, completing a monthly decrease of -1.5054% or -₩350. Over the past 12 months, 007390 stock gained 4.8055%.
007390 is not paying dividends to its shareholders.
Naturecell Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jul 18, 2019.
The company's stock is traded on one exchange.

007390 Chart

People also search for

Samsung Biologics Co., Ltd.
1,569,000
+0.8355%
Celltrion Inc.
201,000
+0.853%
ALTEOGEN Inc.
348,000
+14.0984%
Sk Biopharmaceuticals Co., Ltd.
88,700
+3.8642%
ABL Bio Inc.
93,600
+8.0831%

Naturecell Co., Ltd. (007390) FAQ

What is the stock price today?

The current price is ₩22,900.00.

On which exchange is it traded?

Naturecell Co., Ltd. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 007390.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 1.12T.

Has Naturecell Co., Ltd. ever had a stock split?

Naturecell Co., Ltd. had 2 splits and the recent split was on Jul 18, 2019.

Naturecell Co., Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
- CEO
KRX SM Exchange
KR7007390008 ISIN
South Korea Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Naturecell Co., Ltd. represents the forefront of the biopharmaceutical domain, concentrating its efforts on the development, production, and commercialization of novel cell therapy products. Operating within the dynamic biotechnology industry, the company seeks to harness the potential of stem cell technologies in order to introduce groundbreaking treatment modalities for a variety of health disorders. Its commitment to research and development is aimed at pioneering therapies that can stimulate the regenerative capacities of the human body, especially for conditions with scarce treatment options. Naturecell Co., Ltd.'s mission to address unmet medical needs is indicative of its broader vision to markedly improve health outcomes through advanced therapeutic solutions. The significance of Naturecell Co., Ltd. in the market is a testament to the increasing relevance of biotechnology and regenerative medicine in contemporary healthcare. By pouring investments into state-of-the-art research and deploying sophisticated biotechnologies, Naturecell positions itself as a pivotal contributor to the ongoing transformation of medical treatments. Its dedication to innovation and the practical application of cell therapy underscores the company's integral role in achieving the global objective of realizing sustainable and efficacious healthcare solutions.

Products and Services

  • Cell Therapy Products

    Naturecell Co., Ltd. specializes in the development of cell therapy products designed to treat a range of diseases by promoting the body's natural regenerative processes. These products are the culmination of extensive research and innovation in stem cell technology. Aimed at diseases currently with limited treatment options, Naturecell's cell therapy products represent a significant advance in medical science, potentially offering new hope for patients worldwide.

  • Stem Cell Technologies

    The company leverages cutting-edge stem cell technologies as a cornerstone of its product development strategies. These technologies are employed to engineer therapies that can regenerate damaged tissues and organs, thereby offering solutions for complex medical conditions that are difficult to treat with conventional methods. Naturecell's commitment to stem cell research and application showcases its role in pushing the boundaries of what is achievable in regenerative medicine.

  • Research and Development (R&D)

    A key service area for Naturecell Co., Ltd. is its dedicated research and development division, focused on creating innovative therapies that can enhance the human body's healing and regenerative capabilities. This continual investment in R&D ensures that Naturecell remains at the cutting edge of biotechnological advancements, contributing significantly to the field of regenerative medicine and beyond. The firm's R&D efforts underline its dedication to discovering sustainable healthcare solutions that can meet the evolving needs of patients globally.

Contact Information

Address: -
Phone: -